Paper
Organic & Biomolecular Chemistry
(d, J = 8.7 Hz, 2H), 6.08 (s, 1H), 4.28 (s, 2H), 3.80 (s, 3H), 2.33 129.6, 126.7, 126.6, 124.6, 123.9, 123.8, 120.6, 115.1, 108.9,
(s, 3H); 13C NMR (CDCl3, 75 MHz) δC 158.4, 144.6, 141.6, 73.2, 38.7, 31.6, 25.4, 23.8, 21.5; HRMS (EI+) calcd for
137.2, 136.1, 130.4, 130.0, 129.7, 129.4, 126.3, 124.0, 123.4, C25H27NO4S [M]+ 437.16608, found 437.16599.
120.2, 114.6, 113.8, 110.7, 55.3, 34.4, 21.5; HRMS (EI+) calcd
for C23H21NO3S [M]+ 391.12421, found 391.12415.
(E)-Benzyl 4-(1-tosyl-1H-indol-2-yl)but-3-enoate (12c). Light
yellow amorphous solid (53.0 mg, 34% yield); 1H NMR (CDCl3,
2-(4-Carbomethoxybenzyl)-1-tosyl-1H-indole (9j). Light green 300 MHz) δH 8.17 (d, J = 8.4 Hz, 1H), 7.61 (d, J = 8.4 Hz, 2H),
solid (111.5 mg, 70% yield); mp 56–58 °C; IR (KBr) 2949, 1720, 7.42–7.35 (m, 6H), 7.30–7.15 (m, 3H), 7.09 (d, J = 8.1 Hz, 2H),
1604, 1444, 1368, 1280 cm−1 1H NMR (CDCl3, 300 MHz) 6.66 (s, 1H), 6.24 (dt, J = 15.3, 7.2 Hz, 1H), 5.19 (s, 2H),
;
δH 8.16 (d, J = 8.1 Hz, 1H), 7.94 (d, J = 8.1 Hz, 2H), 7.51 (d, 3.40–3.38 (m, 2H), 2.28 (s, 3H); 13C NMR (CDCl3, 75 MHz)
J = 8.1 Hz, 2H), 7.38 (d, J = 7.5 Hz, 1H), 7.30–7.18 (m, 4H), 7.12 δC 171.0, 144.7, 138.7, 137.1, 135.7, 135.2, 129.9, 129.6, 128.6,
(d, J = 8.1 Hz, 2H), 6.25 (s, 1H), 4.41 (s, 2H), 3.92 (s, 3H), 2.32 128.3, 128.2, 126.7, 126.6, 126.3, 125.9, 124.6, 124.4, 123.9,
(s, 3H); 13C NMR (CDCl3, 75 MHz) δC 166.9, 144.7, 143.4, 120.6, 115.1, 109.0, 66.7, 38.2, 21.5; HRMS (EI+) calcd for
139.5, 137.2, 135.9, 129.7, 129.2, 128.5, 126.2, 124.3, 123.5, C26H23NO4S [M]+ 445.13478, found 445.13467.
120.3, 114.7, 111.2, 52.0, 35.1, 21.5; HRMS (EI+) calcd for
C24H21NO4S [M]+ 419.11913, found 419.11908.
(E)-4-(1-Tosyl-1H-indol-2-yl)but-3-enamide (12d). Brown solid
(74.4 mg, 60% yield); mp 72–74 °C; IR (KBr) 3446, 1668,
2-(2,4-Dimethoxypyrimidin-5-yl)methyl-1-tosyl-1H-indole 1366 cm−1; H NMR (CDCl3, 300 MHz) δH 8.14 (d, J = 8.1 Hz,
(9k).7g Brown amorphous solid (102.9 mg, 64% yield); 1H NMR 1H), 7.60 (d, J = 8.1 Hz, 2H), 7.42 (d, J = 7.5 Hz, 1H), 7.31–7.21
(CDCl3, 300 MHz) δH 8.15 (d, J = 8.4 Hz, 1H), 8.01 (s, 1H), 7.66 (m, 2H), 7.17–7.05 (m, 3H), 6.68 (s, 1H), 6.31–6.21 (m, 1H),
(d, J = 8.1 Hz, 2H), 7. 34 (d, J = 7.8 Hz, 1H), 7.29–7.16 (m, 4H), 5.80 (brs, 1H), 5.44 (brs, 1H), 3.26 (d, J = 6.6 Hz, 2H), 2.31 (s,
6.05 (s, 1H), 4.21 (s, 2H), 3.99 (s, 3H), 3.91 (s, 3H), 2.34 (s, 3H); 3H); 13C NMR (CDCl3, 75 MHz) δC 173.0, 144.9, 138.4, 137.0,
13C NMR (CDCl3, 150 MHz) δC 169.3, 164.7, 158.1, 144.7, 135.1, 129.8, 129.7, 127.0, 126.5, 124.8, 124.7, 123.9, 120.7,
139.0, 137.3, 136.1, 129.8, 129.3, 126.4, 124.2, 120.3, 123.6, 115.0, 109.2, 40.0, 21.4; HRMS (EI+) calcd for C19H18N2O3S
1
114.7, 111.7, 110.2, 54.8, 54.0, 26.2, 21.6.
[M]+ 354.10381, found 354.10376.
(E)-N,N-Dimethyl-4-(1-tosyl-1H-indol-2-yl)but-3-enamide
(12e). Yellow solid (82.9 mg, 62% yield); mp 110–112 °C; IR
General procedure for the synthesis of 2-vinylic indoles 12
;
To a well-stirred solution of Pd(OAc)2 (7.8 mg, 0.035 mmol, (KBr) 1639, 1595, 1546, 1494, 1396, 1363 cm−1 1H NMR
10 mol%) and NaI (104.3 mg, 0.70 mmol) in dry THF (6 mL) (CDCl3, 300 MHz) δH 8.14 (d, J = 8.1 Hz, 1H), 7.61 (d, J = 8.1
were added successively alkene 11 (2.10 mmol) and acetylene Hz, 2H), 7.41 (d, J = 7.2 Hz, 1H), 7.28–7.21 (m, 2H), 7.19–7.09
7b (100 mg, 0.35 mmol) and the reaction mixture was (m, 3H), 6.69 (s, 1H), 6.36–6.31 (m, 1H), 3.39 (dd, J = 6.9, 0.9
allowed to stir at room temperature under oxygen pressure Hz, 2H), 3.10 (s, 3H), 3.01 (s, 3H), 2.30 (s, 3H); 13C NMR
(balloon). After completion of the reaction (TLC), the solvent (CDCl3, 75 MHz) δC 170.4, 144.7, 138.9, 136.9, 135.2, 130.0,
was removed in vacuo; the residue was mixed with water 129.6, 127.9, 126.6, 124.5, 123.8, 123.2, 120.6, 115.0, 108.9,
(10 mL) and then extracted with ethyl acetate (3 × 20 mL). The 37.9, 37.4, 35.5, 21.5; HRMS (EI+) calcd for C21H22N2O3S [M]+
combined organic extracts were washed with brine (10 mL), 382.13511, found 382.13528.
dried over anhydrous Na2SO4, filtered, and concentrated under
(E)-1-Morpholino-4-(1-tosyl-1H-indol-2-yl)but-3-en-1-one (12f).
reduced pressure. The resulting residue was purified through Yellow amorphous solid (92.1 mg, 62% yield); 1H NMR (CDCl3,
silica gel (100–200 mesh) column chromatography (ethyl 500 MHz) δH 8.12 (d, J = 8.5 Hz, 1H), 7.60 (d, J = 8.0 Hz, 2H),
acetate–petroleum ether) to afford pure product 12.
7.40 (d, J = 7.5 Hz, 1H), 7.27–7.24 (m, 1H), 7.19 (t, J = 7.5 Hz,
(E)-Methyl-4-(1-tosyl-1H-indol-2-yl)but-3-enoate (12a). Light 1H), 7.15–7.11 (m, 3H), 6.69 (s, 1H), 6.31 (dt, J = 15.0, 6.5 Hz,
yellow solid (77.5 mg, 60% yield); mp 66–68 °C; IR (KBr) 2951, 1H), 3.70 (t, J = 4.5 Hz, 4H), 3.67–3.66 (m, 2H), 3.55 (t, J =
1737, 1595, 1443, 1369 cm−1 1H NMR (CDCl3, 300 MHz) 4.5 Hz, 2H), 3.38 (d, J = 6.5 Hz, 2H), 2.30 (s, 3H); 13C NMR
;
δH 8.17 (d, J = 8.1 Hz, 1H), 7.63 (d, J = 8.4 Hz, 2H), 7.41 (d, (CDCl3, 125 MHz) δC 169.1, 144.8, 138.8, 137.0, 135.3, 129.9,
J = 7.5 Hz, 1H), 7.30–7.17 (m, 3H), 7.14 (d, J = 7.8 Hz, 2H), 6.68 129.7, 127.2, 126.6, 124.6, 123.9, 123.7, 120.6, 115.1, 109.0,
(s, 1H), 6.22 (dt, J = 15.6, 7.2 Hz, 1H), 3.75 (s, 3H), 3.34 (dd, J = 66.8, 66.6, 46.2, 42.1, 37.7, 21.5; HRMS (EI+) calcd for
7.2, 1.5 Hz, 2H), 2.30 (s, 3H); 13C NMR (CDCl3, 75 MHz) C23H24N2O4S [M]+ 424.14568, found 424.14581.
δC 171.6, 144.7, 138.7, 137.1, 135.3, 129.9, 129.6, 126.7, 126.0,
124.6, 124.2, 123.9, 120.6, 115.1, 109.0, 52.0, 38.0, 21.5; HRMS solid (74.1 mg, 63% yield); mp 62–64 °C; IR (KBr) 3067, 2924,
(EI+) calcd for C20H19NO4S [M]+ 369.10348, found 369.10333. 2251, 1596, 1493, 1370 cm−1 1H NMR (CDCl3, 600 MHz) δH
(E)-4-(1-Tosyl-1H-indol-2-yl)but-3-enenitrile
(12g). Brown
;
(E)-Cyclohexyl 4-(1-tosyl-1H-indol-2-yl)but-3-enoate (12b). 8.19 (d, J = 8.4 Hz, 1H), 7.62 (d, J = 8.4 Hz, 2H), 7.44 (d, J = 7.8
Light brown amorphous solid (65.8 mg, 43% yield); 1H NMR Hz, 1H), 7.36 (d, J = 15.6 Hz, 1H), 7.33–7.30 (m, 1H), 7.23 (t, J =
(CDCl3, 300 MHz) δH 8.19 (d, J = 8.4 Hz, 1H), 7.65 (d, J = 7.5 Hz, 1H), 7.18 (d, J = 7.8 Hz, 2H), 6.69 (s, 1H), 5.99 (dt, J =
8.1 Hz, 2H), 7.43 (d, J = 7.5 Hz, 1H), 7.32–7.20 (m, 3H), 7.16 16.2, 6.0 Hz, 1H), 3.35 (dd, J = 6.0, 1.8 Hz, 2H), 2.32 (s, 3H);
(d, J = 7.8 Hz, 2H), 6.69 (s, 1H), 6.31–6.20 (m, 1H), 4.87–4.80 13C NMR (CDCl3, 150 MHz) δC 145.0, 137.2, 137.1, 135.3,
(m, 1H), 3.33 (d, J = 6.6 Hz, 2H), 2.32 (s, 3H), 1.92–1.84 129.8, 129.5, 126.5, 125.9, 125.2, 124.0, 120.9, 120.7, 116.9,
(m, 2H), 1.79–1.75 (m, 2H), 1.63–1.24 (m, 6H); 13C NMR 115.0, 109.6, 21.5, 20.9; HRMS (EI+) calcd for C19H16N2O2S
(CDCl3, 75 MHz) δC 170.6, 144.7, 138.9, 137.1, 135.3, 129.9, [M]+ 336.09325, found 336.09311.
746 | Org. Biomol. Chem., 2014, 12, 741–748
This journal is © The Royal Society of Chemistry 2014